Geneos Wealth Management Inc. Cytokinetics Inc Transaction History

Geneos Wealth Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$33.93 - $48.92 $339 - $489	-10 Reduced 1.96%	500 $19,000
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $297 - $460	10 Added 2.0%	510 $18,000
Q4 2021 Feb 09, 2022	SELL	$34.35 - $46.38 $17,175 - $23,190	-500 Reduced 50.0%	500 $22,000
Q2 2021 Jul 08, 2021	SELL	$19.79 - $26.99 $9,895 - $13,495	-500 Reduced 33.33%	1,000 $20,000
Q4 2020 May 19, 2021	BUY	$15.26 - $28.61 $7,630 - $14,305	500 Added 50.0%	1,500 $35,000
Q1 2016 Sep 07, 2021	BUY	N/A	1,000	1,000 $7,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.88B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.